IE 11 is not supported. For an optimal experience visit our site on another browser.

Johnson & Johnson vaccine may be less effective against delta variant, study says

00:44

A new study finds that the Johnson & Johnson vaccine may be less effective against the delta variant, which now accounts for 83 percent of all new coronavirus cases in the U.S. NBC’s Gabe Gutierrez reports for TODAY.